Half-dose depot triptorelin in pituitary suppression for multiple ovarian stimulation in assisted reproduction technology: a randomized study*
article
OA: bronze
CC0
⤵ 1 in-corpus citation
AI-generated summary
A half-dose of depot triptorelin was found to be effective for pituitary suppression in assisted reproduction, resulting in more mature and fertilized oocytes and embryos compared to a full dose.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
BACKGROUND: Pituitary suppression by depot GnRH agonist may be excessive for ovarian stimulation in assisted reproduction technology. This study compares the efficacy of standard and half-dose depot triptorelin in a long protocol. METHODS: A total of 180 patients were randomized into two groups using sealed envelopes. Pituitary desensitization was obtained in group 1 (90 patients) with half-dose (1.87 mg) triptorelin depot in the mid-luteal phase of their menstrual cycle, and in group 2 (90 patients) with full-dose (3.75 mg) triptorelin. RESULTS: There was no premature LH surge, with LH levels being lower in the full-dose group (1.04+/-0.05 versus 0.7+/-0.06 IU/l on the day of hCG). The number of FSH ampoules used was lower in group 1 (42+/-2 versus 59+/-3). The numbers of mature oocytes (10.1+/-0.54 versus 7.4+/-0.55), of fertilized oocytes (8.24+/-0.35 versus 6.34+/-0.37) and of embryos (7.8+/-0.36 versus 5.9+/-0.37) were significantly higher in group 1. No significant differences were found in pregnancy (38.8 versus 25.3%), implantation (22.6 versus 13.8%) or abortion (6.1 versus 5.0%) rates. Cumulative pregnancy (fresh plus frozen embryo transfers: 56.8 versus 35.4%) rate was significantly higher in group 1. CONCLUSION: A half-dose of depot triptorelin can be successfully used in ovarian stimulation for IVF and produce a higher number of good quality embryos with a good chance of implantation.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (1)
References (25)
- doi:10.1007/bf01203956 via openalex
- doi:10.1016/s0015-0282(98)00024-7 via openalex
- doi:10.1093/humrep/13.7.1788 via openalex
- doi:10.1093/oxfordjournals.humrep.a137832 via openalex
- doi:10.1093/humrep/15.11.2333 via openalex
- doi:10.1093/humrep/17.12.3129 via openalex
- doi:10.1210/endo-125-3-1739 via openalex
- doi:10.1093/humrep/16.3.492 via openalex
- doi:10.1093/oxfordjournals.humrep.a019506 via openalex
- doi:10.1016/s0015-0282(16)60190-5 via openalex
- doi:10.1016/s0015-0282(99)00608-1 via openalex
- doi:10.1210/jcem.86.1.7108 via openalex
- doi:10.1210/jcem-54-5-1078 via openalex
- doi:10.1016/s0015-0282(16)54114-4 via openalex
- doi:10.1016/s0015-0282(16)60435-1 via openalex
- doi:10.1093/oxfordjournals.humrep.a019348 via openalex
- doi:10.1210/jcem-61-5-834 via openalex
- doi:10.1093/humrep/16.7.1409 via openalex
- doi:10.1016/s0015-0282(02)03228-4 via openalex
- doi:10.1016/s1472-6483(10)61729-4 via openalex
- doi:10.1126/science.377491 via openalex
- doi:10.1016/0020-7292(92)90994-t via openalex
- doi:10.1016/s0015-0282(16)56889-7 via openalex
- doi:10.1210/endo.137.12.8940363 via openalex
- doi:10.1016/s0015-0282(16)60437-5 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-05-11T05:40:41.230350+00:00
License: CC0
· commercial use OK